Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...

Intel's strategic shift to foundry investments has damaged its core business, leading to declining revenue, profitability, ...

JD.com trades at a low P/E despite strong growth, with policy support and trade optimism offering upside amid China risks.

Celestica's Q2 consensus remains conservative despite robust Q1 results. Click here to see why CLS stock is a Buy.

Lumen's transformation shows promise with stable revenue, earnings surprises and cost-saving initiatives. See why I maintain ...

Rocket Lab is firing on all cylinders, which has driven the stock price to all-time highs. Click here to read an analysis of ...

Backdrop: The United States is only one of a handful of markets where Coca-Cola ( NYSE: KO) produces its flagship drink with ...

Betsson remains a high-quality iGaming operator with resilient margins, strong cash generation, and a clear path to 40%+ ...

Clover Health is growing Medicare Advantage and improving margins, but ongoing losses and unproven tech keep upside limited.

Amazon’s AWS strength and Prime Day momentum offset tariff risks and margin headwinds, with valuation still appealing. See ...

Healthcare REITs have outperformed major indices, but several are now trading at significant premiums to fair value. Read why ...

Stem has restructured debt and boosted margins through a software pivot, but policy risks may cap long-term growth. Read why ...